trial, patients paxil cr oral panic disorder assigned to paroxetine demonstrated a lower relapse rate compared to patients on placebo (see CLINICAL PHARMACOLOGY— paxil cr oral TRIALS). Nevertheless, the paxil cr oral who prescribes PAXIL for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual.

to the DSM-IIIR category of panic disorder (see CLINICAL PHARMACOLOGY— paxil cr oral TRIALS).Panic disorder paxil cr oral is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which 4 paxil cr oral more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart, or accelerated heart rate; paxil cr oral sweating; (3) trembling or shaking; (4) sensations paxil cr oral shortness of breath or paxil cr oral (5) feeling of paxil cr oral (6) chest pain or discomfort; (7) nausea or abdominal distress; paxil cr oral feeling dizzy, unsteady, lightheaded, or faint; (9) derealization (feelings of unreality) or paxil cr oral (being detached from oneself); (10) fear paxil cr oral losing control; (11) paxil cr oral of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes.Long-term maintenance of efficacy was paxil cr oral in a 3-month relapse prevention trial. In this trial, patients paxil cr oral panic disorder assigned to paroxetine demonstrated a lower relapse rate.

change in sleep, psychomotor agitation or retardation, paxil cr oral of interest in usual activities or decrease in sexual drive, increased.